Skip to main content
Fangzhou Inc. logo

Fangzhou Inc. — Investor Relations & Filings

Ticker · 6086 LEI · 254900EFB6KUQZPPCC72 HKEX Human health and social work activities
Open in API
Filings indexed 77 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 6086

About Fangzhou Inc.

http://investors.jianke.com

Fangzhou Inc. is a leading online platform specializing in chronic disease management. The company provides comprehensive healthcare technology solutions, operating primarily through segments such as Online Retail Pharmacy Services and Comprehensive Medical Services via its Jianke Platform. Fangzhou focuses on leveraging AI to expand and enhance its chronic disease management offerings, serving a substantial user base reported to exceed 52 million registered users.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2026
Regulatory Filings
2026-05-06 English
2025 Annual Report
Regulatory Filings
2026-04-24 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2026
Regulatory Filings Classification · 1% confidence The document is a routine monthly return (Form FF301) filed with the Hong Kong Stock Exchange under Chapter 19B of the Listing Rules, detailing movements in authorised and issued share capital, public float confirmation, and other regulatory disclosures. It is not an earnings release, management discussion, or a proxy statement, nor is it announcing a discrete event like a dividend or M&A. Therefore, it falls into the general “Regulatory Filings” category (fallback) rather than a more specific reporting type.
2026-04-02 English
List of Directors and their Roles and Functions
Board/Management Information Classification · 1% confidence The document is a public announcement on the Hong Kong Stock Exchange disclosing the current members of the board of directors and their roles, including committee memberships. This fits the definition of a Board/Management Information filing, which covers announcements regarding the company's board composition.
2026-03-26 English
APPOINTMENT OF CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR
Board/Management Information Classification · 1% confidence The document is an official announcement by Fangzhou Inc. on the Stock Exchange of Hong Kong regarding the appointment of a new Chief Executive Officer and executive Director, including biographical details and terms of service. This clearly relates to changes in the company’s senior management and board composition rather than reporting financial results or other regulatory filings. Therefore, it matches the Board/Management Information category.
2026-03-26 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025
Annual Report Classification · 1% confidence The document is an 'Announcement of Annual Results' for Fangzhou Inc. for the year ended December 31, 2025. It contains audited consolidated financial statements, business highlights, and a detailed management discussion and analysis (MD&A). While it is an announcement, it provides the full financial results and substantive analysis for the fiscal year, which qualifies it as an Annual Report (10-K) equivalent in the context of Hong Kong Stock Exchange filings. FY 2025
2026-03-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.